이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Advanced Enzyme Technologies 미래 성장
Future 기준 확인 4/6
Advanced Enzyme Technologies (는) 각각 연간 22.4% 및 11.7% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 22.4% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 16% 로 예상됩니다.
주요 정보
22.4%
수익 성장률
22.4%
EPS 성장률
Chemicals 수익 성장 | 18.9% |
매출 성장률 | 11.7% |
향후 자기자본 수익률 | 16.0% |
애널리스트 커버리지 | Low |
마지막 업데이트 | 17 May 2024 |
최근 미래 성장 업데이트
Recent updates
Advanced Enzyme Technologies (NSE:ADVENZYMES) Has Affirmed Its Dividend Of ₹1.00
Jul 13Advanced Enzyme Technologies' (NSE:ADVENZYMES) Returns On Capital Not Reflecting Well On The Business
Apr 08Advanced Enzyme Technologies (NSE:ADVENZYMES) Will Want To Turn Around Its Return Trends
Sep 23Advanced Enzyme Technologies (NSE:ADVENZYMES) Could Be Struggling To Allocate Capital
Feb 03Advanced Enzyme Technologies (NSE:ADVENZYMES) Will Want To Turn Around Its Return Trends
Aug 11With EPS Growth And More, Advanced Enzyme Technologies (NSE:ADVENZYMES) Is Interesting
May 13Returns On Capital At Advanced Enzyme Technologies (NSE:ADVENZYMES) Paint A Concerning Picture
Mar 28The Advanced Enzyme Technologies (NSE:ADVENZYMES) Share Price Has Gained 185%, So Why Not Pay It Some Attention?
Mar 13Don't Ignore The Fact That This Insider Just Sold Some Shares In Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)
Feb 21Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Feb 18I Built A List Of Growing Companies And Advanced Enzyme Technologies (NSE:ADVENZYMES) Made The Cut
Feb 03What Kind Of Investors Own Most Of Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)?
Jan 19What Do The Returns On Capital At Advanced Enzyme Technologies (NSE:ADVENZYMES) Tell Us?
Dec 28The Advanced Enzyme Technologies (NSE:ADVENZYMES) Share Price Has Gained 114%, So Why Not Pay It Some Attention?
Dec 13Have Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Insiders Been Selling Their Stock?
Nov 28Are Strong Financial Prospects The Force That Is Driving The Momentum In Advanced Enzyme Technologies Limited's NSE:ADVENZYMES) Stock?
Nov 20Here's Why I Think Advanced Enzyme Technologies (NSE:ADVENZYMES) Might Deserve Your Attention Today
Nov 05What You Need To Know About Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) Investor Composition
Oct 21Have Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Insiders Been Selling Their Stock?
Oct 06Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Stocks Shoot Up 31% But Its P/E Still Looks Reasonable
Sep 26Our Take On The Returns On Capital At Advanced Enzyme Technologies (NSE:ADVENZYMES)
Sep 21Does Advanced Enzyme Technologies (NSE:ADVENZYMES) Have A Healthy Balance Sheet?
Sep 08Have Insiders Sold Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Shares Recently?
Aug 26Why We're Not Concerned About Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) Share Price
Aug 21Introducing Advanced Enzyme Technologies (NSE:ADVENZYMES), A Stock That Climbed 60% In The Last Year
Aug 20Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) P/E Is On The Mark
Aug 07수익 및 매출 성장 예측
날짜 | 수익 | 수익 | 잉여 현금 흐름 | 작전 현금 | 평균 애널리스트 수 |
---|---|---|---|---|---|
3/31/2026 | 7,888 | 2,114 | 2,105 | 2,405 | 1 |
3/31/2025 | 7,014 | 1,797 | 2,892 | 3,192 | 1 |
3/31/2024 | 6,239 | 1,333 | 941 | 1,414 | N/A |
12/31/2023 | 6,048 | 1,371 | N/A | N/A | N/A |
9/30/2023 | 5,859 | 1,248 | 965 | 1,327 | N/A |
6/30/2023 | 5,668 | 1,166 | N/A | N/A | N/A |
3/31/2023 | 5,406 | 1,056 | 1,022 | 1,404 | N/A |
12/31/2022 | 5,337 | 979 | N/A | N/A | N/A |
9/30/2022 | 5,251 | 960 | 806 | 1,164 | N/A |
6/30/2022 | 5,135 | 995 | N/A | N/A | N/A |
3/31/2022 | 5,294 | 1,196 | 941 | 1,223 | N/A |
12/31/2021 | 5,309 | 1,268 | N/A | N/A | N/A |
9/30/2021 | 5,350 | 1,424 | 1,127 | 1,374 | N/A |
6/30/2021 | 5,325 | 1,500 | N/A | N/A | N/A |
3/31/2021 | 5,018 | 1,459 | 1,434 | 1,630 | N/A |
12/31/2020 | 4,820 | 1,459 | N/A | N/A | N/A |
9/30/2020 | 4,569 | 1,364 | 978 | 1,472 | N/A |
6/30/2020 | 4,481 | 1,301 | N/A | N/A | N/A |
3/31/2020 | 4,440 | 1,293 | 904 | 1,409 | N/A |
12/31/2019 | 4,480 | 1,302 | N/A | N/A | N/A |
9/30/2019 | 4,366 | 1,210 | 1,147 | 1,276 | N/A |
6/30/2019 | 4,288 | 1,148 | N/A | N/A | N/A |
3/31/2019 | 4,220 | 1,111 | 1,162 | 1,286 | N/A |
12/31/2018 | 4,194 | 1,061 | N/A | N/A | N/A |
9/30/2018 | 4,261 | 1,068 | N/A | N/A | N/A |
6/30/2018 | 4,199 | 1,039 | N/A | N/A | N/A |
3/31/2018 | 3,918 | 901 | 1,050 | 1,160 | N/A |
12/31/2017 | 3,660 | 837 | N/A | N/A | N/A |
9/30/2017 | 3,213 | 725 | N/A | N/A | N/A |
6/30/2017 | 3,127 | 793 | N/A | N/A | N/A |
3/31/2017 | 3,290 | 915 | N/A | 1,074 | N/A |
12/31/2016 | 3,260 | 942 | N/A | N/A | N/A |
9/30/2016 | 3,404 | 998 | N/A | N/A | N/A |
6/30/2016 | 3,184 | 854 | N/A | N/A | N/A |
3/31/2016 | 2,938 | 759 | N/A | 934 | N/A |
3/31/2015 | 2,233 | 510 | N/A | 537 | N/A |
3/31/2014 | 2,397 | 201 | N/A | 433 | N/A |
애널리스트 미래 성장 예측
수입 대 저축률: ADVENZYMES 의 연간 예상 수익 증가율( 22.4% )이 saving rate( 6.7% 보다 높습니다. ).
수익 vs 시장: ADVENZYMES 의 연간 수익( 22.4% ) Indian 시장( 15.9% 보다 빠르게 성장할 것으로 예상됩니다. 15.9% 연간).
고성장 수익: ADVENZYMES 의 수입은 향후 3년 동안 상당히 증가할 것으로 예상됩니다.
수익 대 시장: ADVENZYMES 의 수익(연간 11.7% ) Indian 시장( 9.5% 보다 빠르게 성장할 것으로 예상됩니다. 9.5% 연간).
고성장 수익: ADVENZYMES 의 수익(연간 11.7% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.
주당 순이익 성장 예측
미래 자기자본 수익률
미래 ROE: ADVENZYMES 의 자본 수익률은 3년 내에 최저 수준이 될 것으로 예상됩니다( 16 %).